Colgate-Palmolive Company $CL Shares Acquired by Vestcor Inc

Vestcor Inc increased its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 2.6% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 296,010 shares of the company’s stock after purchasing an additional 7,542 shares during the period. Colgate-Palmolive accounts for 0.7% of Vestcor Inc’s investment portfolio, making the stock its 22nd largest holding. Vestcor Inc’s holdings in Colgate-Palmolive were worth $23,663,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of CL. Fieldview Capital Management LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at about $4,760,000. Inceptionr LLC acquired a new position in shares of Colgate-Palmolive in the third quarter valued at approximately $628,000. Private Advisor Group LLC raised its stake in shares of Colgate-Palmolive by 2.4% during the third quarter. Private Advisor Group LLC now owns 79,095 shares of the company’s stock worth $6,323,000 after purchasing an additional 1,826 shares during the last quarter. Diversify Advisory Services LLC grew its position in Colgate-Palmolive by 33.3% in the 3rd quarter. Diversify Advisory Services LLC now owns 17,470 shares of the company’s stock valued at $1,310,000 after buying an additional 4,367 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. AG raised its position in Colgate-Palmolive by 1.2% during the 3rd quarter. B. Metzler seel. Sohn & Co. AG now owns 448,798 shares of the company’s stock worth $35,877,000 after buying an additional 5,471 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

NYSE CL opened at $93.55 on Monday. The business has a 50 day moving average price of $88.98 and a 200 day moving average price of $83.03. The company has a market capitalization of $75.41 billion, a P/E ratio of 35.71, a PEG ratio of 4.22 and a beta of 0.28. Colgate-Palmolive Company has a 1-year low of $74.54 and a 1-year high of $100.18. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the previous year, the business earned $0.91 earnings per share. Colgate-Palmolive’s quarterly revenue was up 5.8% compared to the same quarter last year. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 79.39%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on CL shares. Evercore boosted their price target on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, February 2nd. Bank of America boosted their target price on Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. UBS Group lifted their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research note on Wednesday, January 14th. Deutsche Bank Aktiengesellschaft raised their target price on Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a report on Monday, February 2nd. Finally, Rothschild & Co Redburn set a $93.00 price target on shares of Colgate-Palmolive in a research note on Friday, February 13th. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.75.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 35,000 shares of the firm’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the completion of the transaction, the chief operating officer owned 10,415 shares of the company’s stock, valued at approximately $985,363.15. This trade represents a 77.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Sally Massey sold 15,851 shares of the company’s stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the sale, the insider owned 13,751 shares in the company, valued at $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 184,683 shares of company stock valued at $17,486,693. Insiders own 0.41% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.